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9. Physiotherapy 
~ Chest physiotherapy in Cystic Fibrosis: short-term effects 
of Autogenic Drainage combined with wet inhalation of 
saline (saline-AD) versus Autogenic Drainage combined with 
Intrapulmonary Percussive Ventilation with saline (IPV-AD) 
K. Van Cauwelaert 1 , F. Van Ginderdeuren 1 , S. Verbanck 2, S. Vanlaethem 1 , 
D. Schuermans 2, VV~ Vincken 2, A. Malfroot 1. 1 Cystic Fibrosis Center and 
2Department of Pulmonology, AZ-VUB, Brussels, Belgium 
Aims: This study compared the short-term effects of two physiotherapy regimens in 
CF patients: Autogenic Drainage preceded by wet inhalation of saline (saline AD) 
versus Autogenic Drainage preceded by Intrapulmonary Percussive Ventilation with 
saline (IPV AD). 
Methods: Twenty clinically stable CF patients underwent either saline AD or 
IPV AD on two consecutive days with similar pulmonary function at baseline. 
Effectiveness of either physiotherapy regimen was evaluated by measuring oxygen 
saturation, heart rate, Borg dyspnea score, and mucus wet weight at baseline, after 
15 rain of either saline or IPV, and after a subsequent 30 rain of AD. 
Results: There were no significant changes in oxygen saturation, heart rate or Borg 
score at any point of either physiotherapy intervention. There was no significant 
difference in sputum wet weight recovered with either saline (2.2+1.8(SD) g) or IPV 
(1.7+l.9(SD)g) alone. Subsequent AD did produce significantly greater amounts 
of sputum wet weight (p < 0.0001 for both), yet the amount of wet weight was 
similar irrespective ofwhether AD was preceeded by saline (9.7+6.5 (SD) g) or IPV 
(11.6+7.3 (SD) g). 
Conclusions: In terms of short-term physiotherapy effects, the crucial element with 
respect o mucus expectoration resides in the Autogenic Drainage. The recovered 
sputum is similar when the Autogenic Drainage is preceded by aerosol inhalation 
or by Intrapulmonary Percussive Ventilation. 
Supported by the Belgian Cystic Fibrosis Association. 
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~The value of routinely using the 3-minute Step Test at 
Annual Review 
B. Rijnbende, J. Cowlard, S.B. Carr. Paediatric CF Unit, Barts and The London 
Children ~' HosTital, London, UK 
Exercise testing in CF on an annual basis is a recommendation in the UK 
Cystic Fibrosis Trust's Standards for the Clinical Care of Children and Adults 
with CF (2001). The 3-minute step test is one of the sub-maximal exercise tests 
recommended in these guidelines. 
The aim of this study was to assess the value of doing the 3-minute step test on a 
yearly basis for the purpose of monitoring progress. 
Methods: Data was collected over a 4 year period. Indices measured included, age, 
lung function, height and weight. The 3-minute step was performed as described by 
Balfour-Lynn (Ped Pulm 1998, 25; p. 278). Outcomes were percentage increase in 
pulse rate from baseline, change in oxygen saturation, and perceived breathlessness 
(Borg score). 
Results: 27 children were studied (14 males). Mean age at the start of the study 
was 9.1 years (5.9 14.3).The mean number of annual reviews was 3 (2 5). No 
statistically significant changes were found over the four years (ANOVA). Mean 
change at years 1, 2, 3, 4 and 5 were: Pulse rate change: 44%, 35%, 38%, 46%, 
and 46%. Fall in oxygen saturations: 2.3%, 2.3%, 2.3%, 1.1%, and 1.7%. Borg 
score change: 3, 3.3, 2.3, 1.9, and 4.1. FEVI: 85%, 88%, 78%, 86% and 90% 
respectively. 
Conclusion: This study does not show any significant change in the outcome 
measures recorded for the group as a whole over the 4-year period or between 
years. The value of using the 3-minute step as an exercise test to monitor progress 
in the paediatric population, where lung function shows mild to moderate disease, 
has not been identified. It may be that in advancing disease the 3-minute step has a 
place in monitoring progress and prescribing safe, effective xercise programmes. 
However, we should consider removing the recommendation of using a sub-maximal 
exercise test from the paediatric guidelines. 
• Should community physiotherapy be a standard care package 
with all home intravenous courses? 
J. Keane 1, J. Townsend 2. 1The London Chest HosTital Adult Cystic Fibrosis 
Service, 2physiotherapy Dept. Southend HosTital NHS Trust, UK 
Aim: To identify if there is significant improvement i  the outcome following home 
intravenous antibiotic therapy (IVAT) with, versus those without, community based 
physio input three times a week. 
Method: Adults with cystic fibrosis (CF) who have home IVAT and community 
CF nurse specialist support were asked if they would participate in this study. They 
were given the choice at the beginning of each course whether or not to have 
support of community physio. A validated CF quality of life (QoL) questionnaire, 
an analogue BORG score, clinical measurements including spirometry (FEV1 and 
FVC) and oxygen saturations were taken pre and post course. 
Results: A study of 8 patients, primarily data so far comparing 4 with community 
physio against 4 without. Comparisons of the QoL questionnaire showed a 15% 
overall improvement in those with physio support compared to 10% in those 
without. BORG scores and oxygen saturations did not differ between the two groups. 
There was a significant increase up to 19% in FEV1 and 31% in FVC in those with 
community physio as opposed to 10% in FEV1 and FVC in those who declined. 
Conclusion: The study illustrates the efficacy of home IVAT with the additional 
support of community physiotherapy. The physio group showed a greater improve- 
ment in lung function and QoL following IVAT than the group who declined. 
The study sample is small but the results demonstrate a need for further esearch 
and resource for the provision of community physiotherapy in this patient group. 
The availability of this service allows the patients greater choice over where their 
treatment is delivered with the reassurance of knowing that it is possible to achieve 
good outcomes from treatment in the home environment, which impacts upon 
quality of life. 
• Working in partnership with families to openly monitor aerosol 
therapy with an in-device data logger 
R McCormack, A. McDonald, J.M. Couriel, K.W Southern. Regional Paediatric 
CF Cenlre, Royal Liverpool Children ~' HosTital, Liverpool, UK 
As technology improves, CF teams will be faced with novel means of monitoring 
patient reatment. For example, an adaptive aerosol delivery (AAD) device, the 
I-neb, has an in-device data logger measuring date, time and duration of delivery. 
Traditionally, the monitoring of patient concordance with treatment is undertaken 
in a covert manner, often as part of a clinical trial. We discussed as a team using 
this facility in a more open manner in order to facilitate a change in practice in 
our clinic from a standard nebuliser to the AAD device. We report our experience 
with twenty patients (mean age, 11.2 yrs, range 2.8 17 yrs) who have been using the 
AAD device for an average period of 114 days (range, 18 170). A rapid download of 
data was possible during clinic visits. The average number of treatments undertaken 
was 72 (range, 16 102), with treatment times ranging from 2 to 6 minutes (median, 
3 minutes). In ten patients, issues with concordance were evident and we were able 
to adjust management plans to support hese families (i.e., giving an increased 
dose once a day and organising treatments atschool). Compliance was excellent in 
ten patients, although in three long treatment times were shortened by advice on 
breathing technique. In total, we identified long treatment times in six patients and 
were able to provide advice to address these issues (in two cases with nasal clips but 
in most cases with alterations in breathing technique utilising visual feedback from 
the breathing monitor). Overall patients and families have responded positively to 
the open monitoring of their treatment and in a significant number this has enabled 
interventions that may improve treatment times and concordance. 
